FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200187712> ?p ?o ?g. }

• W4200187712 endingPage "e12547" @default.
• W4200187712 startingPage "e12547" @default.
• W4200187712 abstract "Despite the rise in the use of immune checkpoint blockade drugs (ICBs) in recent years, there are no ICB drugs that are currently approved or under large-scale clinical trials for glioblastoma (GBM). T-cells, which mainly mediate adaptive immunity, are an important part of the tumor immune microenvironment. The activation of T-cells in tumors plays a key role in evaluating the sensitivity of patients to immunotherapy. Therefore, we applied bioinformatics approaches to construct a T-cell activation related risk score to study the effect of the activation of T-cells on the prognosis and ICB response of patients with GBM.This study collected TCGA, CGGA, and GSE16011 glioma cohorts, as well as the IMvigor210 immunotherapy dataset, with complete mRNA expression profiles and clinical information. GraphPad Prism 8 and R 3.6.3 were used for bioinformatics analysis and plotting.The activation of T-cells in patients with GBM is characterized by obvious heterogeneity. We established a T-cell activation-related risk score based on five univariate Cox regression prognostic genes (CD276, IL15, SLC11A1, TNFSF4, and TREML2) in GBM. The risk score was an independent risk factor for poor prognosis. The overall survival time of patients in the high-risk group was significantly lower than in the low-risk group. Moreover, the high-risk score was accompanied by a stronger immune response and a more complex tumor immune microenvironment. Hot tumors were mainly enriched in the high-risk group, and high-risk group patients highly expressed inhibitory immune checkpoints (PD1, PD-L1, TIM3 etc.). By combining the risk and priming scores we obtained the immunotherapy score, which was shown to be a good evaluation index for sensitivity to GBM immunotherapy.As an independent risk factor for poor prognosis, the T-cell activation-related risk score, combined with other clinical characteristics, could efficiently evaluate the survival of patients with GBM. The immunotherapy score obtained by combining the risk and priming scores could evaluate the ICB response of patients with GBM, providing treatment opportunities." @default.
• W4200187712 created "2021-12-31" @default.
• W4200187712 creator A5031681451 @default.
• W4200187712 creator A5034311245 @default.
• W4200187712 creator A5045150831 @default.
• W4200187712 creator A5057881981 @default.
• W4200187712 creator A5060526709 @default.
• W4200187712 creator A5063746689 @default.
• W4200187712 creator A5067340693 @default.
• W4200187712 creator A5089413821 @default.
• W4200187712 date "2021-12-22" @default.
• W4200187712 modified "2023-09-27" @default.
• W4200187712 title "Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma" @default.
• W4200187712 cites W1889335134 @default.
• W4200187712 cites W1910012553 @default.
• W4200187712 cites W1994993231 @default.
• W4200187712 cites W2003571703 @default.
• W4200187712 cites W2028433016 @default.
• W4200187712 cites W2039123767 @default.
• W4200187712 cites W2041532314 @default.
• W4200187712 cites W2105879190 @default.
• W4200187712 cites W2107598346 @default.
• W4200187712 cites W2130473166 @default.
• W4200187712 cites W2142300779 @default.
• W4200187712 cites W2159707944 @default.
• W4200187712 cites W2254576822 @default.
• W4200187712 cites W2403175291 @default.
• W4200187712 cites W2428936938 @default.
• W4200187712 cites W2506616866 @default.
• W4200187712 cites W2533508881 @default.
• W4200187712 cites W2541574334 @default.
• W4200187712 cites W2603523955 @default.
• W4200187712 cites W2622499649 @default.
• W4200187712 cites W2739763813 @default.
• W4200187712 cites W2739998491 @default.
• W4200187712 cites W2749025438 @default.
• W4200187712 cites W2756181170 @default.
• W4200187712 cites W2774712455 @default.
• W4200187712 cites W2796207838 @default.
• W4200187712 cites W2796584001 @default.
• W4200187712 cites W2799416225 @default.
• W4200187712 cites W2801006204 @default.
• W4200187712 cites W2804102248 @default.
• W4200187712 cites W2804408469 @default.
• W4200187712 cites W2810919053 @default.
• W4200187712 cites W2830175972 @default.
• W4200187712 cites W2886498337 @default.
• W4200187712 cites W2899145148 @default.
• W4200187712 cites W2905302554 @default.
• W4200187712 cites W2905562353 @default.
• W4200187712 cites W2949273159 @default.
• W4200187712 cites W2949498852 @default.
• W4200187712 cites W2951280589 @default.
• W4200187712 cites W2959191827 @default.
• W4200187712 cites W2963367647 @default.
• W4200187712 cites W2965985232 @default.
• W4200187712 cites W2966465234 @default.
• W4200187712 cites W2979984433 @default.
• W4200187712 cites W2985170860 @default.
• W4200187712 cites W2998861466 @default.
• W4200187712 cites W3009386543 @default.
• W4200187712 cites W3012668557 @default.
• W4200187712 cites W3021675475 @default.
• W4200187712 cites W3026844837 @default.
• W4200187712 cites W3056214675 @default.
• W4200187712 cites W3092415276 @default.
• W4200187712 cites W3095211697 @default.
• W4200187712 cites W3097339274 @default.
• W4200187712 cites W3115086337 @default.
• W4200187712 cites W3131183594 @default.
• W4200187712 cites W3135035839 @default.
• W4200187712 doi "https://doi.org/10.7717/peerj.12547" @default.
• W4200187712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35036121" @default.
• W4200187712 hasPublicationYear "2021" @default.
• W4200187712 type Work @default.
• W4200187712 citedByCount "1" @default.
• W4200187712 countsByYear W42001877122023 @default.
• W4200187712 crossrefType "journal-article" @default.
• W4200187712 hasAuthorship W4200187712A5031681451 @default.
• W4200187712 hasAuthorship W4200187712A5034311245 @default.
• W4200187712 hasAuthorship W4200187712A5045150831 @default.
• W4200187712 hasAuthorship W4200187712A5057881981 @default.
• W4200187712 hasAuthorship W4200187712A5060526709 @default.
• W4200187712 hasAuthorship W4200187712A5063746689 @default.
• W4200187712 hasAuthorship W4200187712A5067340693 @default.
• W4200187712 hasAuthorship W4200187712A5089413821 @default.
• W4200187712 hasBestOaLocation W42001877121 @default.
• W4200187712 hasConcept C126322002 @default.
• W4200187712 hasConcept C143998085 @default.
• W4200187712 hasConcept C170493617 @default.
• W4200187712 hasConcept C203014093 @default.
• W4200187712 hasConcept C2776090121 @default.
• W4200187712 hasConcept C2776107976 @default.
• W4200187712 hasConcept C2777701055 @default.
• W4200187712 hasConcept C2778227246 @default.
• W4200187712 hasConcept C2778468042 @default.
• W4200187712 hasConcept C2780851360 @default.
• W4200187712 hasConcept C502942594 @default.

• next